Survival Benefit of Synchronous Lenvatinib Combined PD-1 Inhibitors for Advanced Hepatocellular Carcinoma Beyond Oligometastasis

Xu K, Xiang C, Yu Z, Li J, Liu C

ImmunoTargets and Therapy 2024, 13:305-317

Published Date: 17 June 2024